Researchers from iMed.ULisboa publish in Gut
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease with an estimated global prevalence of 24% and to which no effective pharmacological approach has yet been approved.
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease with an estimated global prevalence of 24% and to which no effective pharmacological approach has yet been approved.